Proceedings of the National Academy of Sciences · 2010 · 115 citations · 31 references
MedicineMolecular BiologyOncologyApoptosisCarcinogenesisInflammationDna Damage-induced ApoptosisDna Repair In CarcinogenesisHepatocellular CarcinomaInflammation-associated CarcinogenesisLiver CancerLiver RegenerationDna Damage Response PathwaysDna Damage Response SignalingHepatic ApoptosisHepatocellular Carcinoma PathogenesisHepatocyte ProliferationInflammation-mediated CarcinogenesisInflammatory Liver InjuryLiver Regeneration After Partial Hepatectomy
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide and is considered to be the outcome of chronic liver inflammation. Currently, the main treatment for HCC is surgical resection. However, survival rates are suboptimal partially because of tumor recurrence in the remaining liver. Our aim was to understand the molecular mechanisms linking liver regeneration under chronic inflammation to hepatic tumorigenesis. Mdr2-KO mice, a model of inflammation-associated cancer, underwent partial hepatectomy (PHx), which led to enhanced hepatocarcinogenesis. Moreover, liver regeneration in these mice was severely attenuated. We demonstrate the activation of the DNA damage-response machinery and increased genomic instability during early liver inflammatory stages resulting in hepatocyte apoptosis, cell-cycle arrest, and senescence and suggest their involvement in tumor growth acceleration subsequent to PHx. We propose that under the regenerative proliferative stress induced by liver resection, the genomic unstable hepatocytes generated during chronic inflammation escape senescence and apoptosis and reenter the cell cycle, triggering the enhanced tumorigenesis. Thus, we clarify the immediate and long-term contributions of the DNA damage response to HCC development and recurrence.
31
Experimental pathology of the liver
Gm. Higgins · Medical Entomology and Zoology · 1931 · 3.1K citations
Medicine, Pathobiology, Pathology +12
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Jiřina Bártková, Zuzana Hořejšı́, Karen Koed et al. · Nature · 2005 · 2.7K citations
Medicine, Cancer Biology, Oncology +16
NF-κB functions as a tumour promoter in inflammation-associated cancer
Eli Pikarsky, Rinnat M. Porat, Ilan Stein et al. · Nature · 2004 · 2.4K citations